Provided by Tiger Fintech (Singapore) Pte. Ltd.

LEE'S PHARM

1.320
+0.000
Volume:- -
Turnover:- -
Market Cap:777.26M
PE:8.35
High:1.320
Open:1.320
Low:1.320
Close:1.320
Loading ...

Company Profile

Company Name:
LEE'S PHARM
Exchange:
SEHK
Establishment Date:
1994
Employees:
1022
Office Location:
Building 20E,1st Floor,Phase 3,Hong Kong Science Park,Shatin,New Territories,Hong Kong
Zip Code:
- -
Fax:
852 2314 1708
Introduction:
Lee’s Pharmaceutical Holdings Limited is a Hong Kong-based investment holding company principally engaged in the development, manufacture, marketing and sales of pharmaceutical products. The Company operates through two segments. Proprietary Products segment is engaged in the manufacture and sales of self-developed pharmaceutical products. Its proprietary products include Yallaferon, Livaracine and Slounase, among others. Licensed-in Products segment is engaged in the trading of licensed-in pharmaceutical products. Its licensed-in products include Ferplex and Zanidip, among others. The Company’s products are for cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology, among others. The Company mainly operates businesses in China and Hong Kong.